Skin Experts: Melanotan Can Cause Changes In Moles

Armen Hareyan's picture
Advertisement

Consumers should display caution when using unlicensed skin care products. Melanotan (an unlicensed medicine dubbed the "tan jab") can cause rapid changes in the appearance of moles, warn skin experts in this week's BMJ.

There are two types of Melanotan - Melanotan I and Melanotan II. They work by increasing the levels of melanin (the body's natural pigment that protects us from the sun) resulting in a suntan.

Advertisement

Melanotan has not been tested by the medicines regulator, but both products are being advertised and sold illegally as an injectable tan on the internet and in some tanning salons and body building gyms.

The authors describe two patients attending their dermatology clinic with rapidly changing moles and an intense tan, despite their fair skin type. They were both sunbed users and both had injected Melanotan I and II, bought from the internet, shortly before their moles changed.

The Medicines and Healthcare products Regulatory Agency (MRHA) recently raised concerns about the health risks of these counterfeit drugs, say the authors. These cases highlight a further area of concern - changes in the appearance of existing moles.

They warn that unregulated use of Melanotan may lead to an increase in the number of patients seeking medical advice about changing moles and may even confuse the diagnosis. They suggest healthcare professionals look out for unexpected tanning as a clue to such use.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement

Comments

There have been a couple of publications relative to this story that folks may want to read: Wired : http://www.wired.com/wiredscience/2009/01/tan/ The Sun: http://www.thesun.co.uk/sol/homepage/showbiz/bizarre/2432759/An-amazing-new-drug-that-protects-against-skin-cancer-is-set-for-launch-next-year.html Cheers, http://melanotan.org/ - afamelanotide
Time for an update about this? melanotan-1 (afamelanotide / Scenesse) has gotten approval from the Italian Medicines Agency for treating sufferers of EPP: info: http://melanotan.org/#Scenesse